한국어
English
日本語
中文(简体)
Karendia Tablet 20 mg (Finerenone)
20mg
Tablet · Prescription medication
Bayer Korea Co., Ltd.
Finerenone is an active pharmaceutical ingredient that helps protect the cardiovascular system and inhibit the progression of chronic kidney disease.
MFDS ingredient code M282670
Finerenone is a non-steroidal mineralocorticoid receptor antagonist primarily used in the treatment of cardiovascular diseases and chronic kidney diseases. This ingredient aims to reduce inflammation and fibrosis in the body, preventing deterioration of heart and kidney function.
Finerenone binds to mineralocorticoid receptors, blocking the action of aldosterone. This action reduces inflammation and fibrosis, preventing damage to heart and kidney tissues and protecting their functions.
Approved uses differ by product. Check each product's information for its actual use.
Unlike traditional steroidal mineralocorticoid receptor antagonists, finerenone has a non-steroidal structure, which reduces the risk of side effects and increases selectivity. This characteristic improves the cardiovascular and kidney protective effects.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.